Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia

References

• Faderl S., Kantarjian H. M., Talpaz M., Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 1998; 91: 3955–4019
   Google Scholar
• Third International Workshop on Chromosomes in Leukemia. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia. Cancer Res 1983; 43: 868–873
   PubMed Web of Science ®Google Scholar
• Groupe Français de Cytogénétique Hématologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia. Correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogénétique Hématologique. Blood 1996; 87: 3135–3142
   PubMed Web of Science ®Google Scholar
• Rieder H., Ludwig W.-D., Gassmann W., Thiel E., Löffler H., Hoelzer D., Fonatsch C. Chromosomal abnormalities in adult acute lymphoblastic leukemia: Results of the German ALL/AUL study group. Recent Results Cancer Res 1993; 131: 133–148
   PubMedGoogle Scholar
• Fenaux P., Lai J. L., Morel P., Nelken B., Taboureau O., Deminatti M., Bauters F. Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3. Hematol Oncol 1989; 7: 307–317
   PubMed Web of Science ®Google Scholar
• Secker-Walker L. M., Prentice H. G., Durrant J., Richards S., Hall E., Harrison G. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol 1997; 96: 601–610
   PubMed Web of Science ®Google Scholar
• Bloomfield C. D., Secker-Walker L. M., Goldman A. I., Van Den Berghe H., de la Chapelle A., Ruutu T., Alimena G., Garson O. M., Golomb H. M., Rowley J. D., Kaneko Y., Whang-Peng J., Prigogina E., Philip P., Sandberg A. A., Lawler S. D., Mitelman F. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989; 40: 171–185
   PubMed Web of Science ®Google Scholar
• Nowell P. C., Hungerford D. A. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497
   Web of Science ®Google Scholar
• Kurzrock R., Gutterman J. U., Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988; 319: 990–998
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Talpaz M., Dhingra K., Estey E., Keating M. J., Ku S., Trujillo J., Huh Y., Stass S., Kurzrock R. Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411–2418
   PubMed Web of Science ®Google Scholar
• Preti H. A., O'Brien S., Giralt S., Beran M., Pierce S., Kantarjian H. M. Philadelphia-chromosome-positive adult acute lymphocytic leukemia: Characteristics, treatment results, and prognosis in 41 patients. Am J Med 1994; 97: 60–65
   PubMed Web of Science ®Google Scholar
• Götz G., Weh H.-J., Walter T. A., Kuse R., Kolbe K., Dölken G., Hellriegel K. P., Hoelzer D., Hossfeld D. K. Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia. Ann Hematol 1992; 64: 97–100
   PubMed Web of Science ®Google Scholar
• Maurer J., Janssen J. W.G., Thiel E., Van Denderen J., Ludwig W.-D., Aydemir Ü., Heinze B., Fonatsch C., Harbott J., Reiter A., Riehm H., Hoelzer D., Bartram C. R. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991; 337: 3995–4019
   Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A.G., Gralnick H. R., Sultan C. Proposals for the classification of acute leukemia. Br J Haematol 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Walters R. S., Keating M. J., Smith T. L., O'Brien S., Estey E. H., Huh Y. O., Spinolo J., Dicke K., Barlogie B., McCredie K. B., Freireich E. J. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol 1990; 8: 994–1004
   PubMed Web of Science ®Google Scholar
• Keating M. J., Cork A., Broach Y., Smith T., Walters R. S., McCredie K. B., Trujillo J., Freireich E. J. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leuk Res 1987; 11: 119–133
   PubMed Web of Science ®Google Scholar
• Murphy S. B., Bowman W. P., Abromowitch M., Mirro J., Ochs J., Rivera G., Pui C. H., Fairclough D., Berard C. W. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732–1739
   PubMed Web of Science ®Google Scholar
• Kantarjian H., O'Brien S., Beran M., Keating M., Koller C., Robertson L., Andreeff M., Murphy S., Freireich E. J. Update of the hyper-CVAD program in newly diagnosed adult acute lymphocytic leukemia (ALL). Blood 1995; 86: 173a, (abstr)
   Google Scholar
• Keating M. J., Gehan E. A., Smith T. L., Estey E. H., Walters R. S., Kantarjian H. M., McCredie K. B., Freireich E. J. A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia. J Clin Oncol 1987; 5: 710–721
   PubMed Web of Science ®Google Scholar
• Kaplan E. S., Meier P. Non-parametric estimations form incomplete observations. Am Stat Assoc J 1958; 53: 457
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163
   PubMedGoogle Scholar
• Bloomfield C. D., Peterson L. C., Yunis J. J., Brunning R. D. The Philadelphia chromosome (Ph1) in adults presenting with acute leukaemia: A comparison of Ph1 + and Ph1- patients. Br J Haematol 1977; 36: 347–358
   PubMed Web of Science ®Google Scholar
• Specchia G., Mininni D., Guerrasio A., Palumbo G., Pastore D., Liso V. Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies. Leuk Lymphoma 1995; 18(Suppl 1)37–42
   PubMed Web of Science ®Google Scholar
• Koller C. A., Kantarjian H. M., Thomas D., O'Brien S., Rios M. B., Kornblau S., Murphy S., Keating M. The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia 1997; 11: 2039–2044
   PubMed Web of Science ®Google Scholar
• Rieder H., Ludwig W.-D., Gassmann W., Maurer J., Janssen J. W.G., Gökbuget N., Schwartz S., Thiel E., Löffler H., Bartram C. R., Hoelzer D., Fonatsch C. Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome postivie acute lymphoblastic leukemia. Br J Haematol 1996; 95: 678–691
   PubMed Web of Science ®Google Scholar
• Secker-Walker L. M., Craig J. M., Hawkins J. M., Hoffbrand A. V. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia 1990; 5: 196–199
   Web of Science ®Google Scholar
• Ribeiro R. C., Broniscer A., Rivera G. K., Hancock M. L., Raimondi S. C., Sandlund J. T., Crist W., Evans W. E., Pui C.-H. Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia 1997; 11: 1493–1496
   PubMed Web of Science ®Google Scholar
• Thomas X., Thiebaut A., Olteanu N., Danaíla C., Charrin C., Archimbaud E., Fiere D. Philadelphia chromosome postitive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome. Hematol Cell Ther 1998; 40: 119
   PubMedGoogle Scholar
• Westbrook C., Hooberman A. L., Spino C., Dodge R. K., Larson R. A., Davey F., Wurster-Hill D. H., Sobol R. E., Schiffer C., Bloomfield C. D. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B Study (8762). Blood 1992; 80: 2983–2990
   PubMed Web of Science ®Google Scholar